-
1
-
-
33646790534
-
Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy
-
J. Bełtowski, and A. Kedra Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy Pharmacol. Rep. 58 2006 159 178
-
(2006)
Pharmacol. Rep.
, vol.58
, pp. 159-178
-
-
Bełtowski, J.1
Kedra, A.2
-
2
-
-
70350057304
-
Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-an update on patient populations with a wide range of cardiovascular risk
-
R.H. Böger, R. Maas, F. Schulze, and E. Schwedhelm Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-an update on patient populations with a wide range of cardiovascular risk Pharmacol. Res. 60 2009 481 487
-
(2009)
Pharmacol. Res.
, vol.60
, pp. 481-487
-
-
Böger, R.H.1
Maas, R.2
Schulze, F.3
Schwedhelm, E.4
-
3
-
-
79952200255
-
Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats
-
G.F. Chen, L. Wagner, J.M. Sasser, S. Zharikov, N.C. Moningka, and C. Baylis Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats Nephrol. Dial. Transplant. 25 2010 3518 3525
-
(2010)
Nephrol. Dial. Transplant.
, vol.25
, pp. 3518-3525
-
-
Chen, G.F.1
Wagner, L.2
Sasser, J.M.3
Zharikov, S.4
Moningka, N.C.5
Baylis, C.6
-
4
-
-
33646830648
-
Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: A clinical review
-
DOI 10.1097/01.hjh.0000226182.60321.69, PII 0000487220060600000001
-
D.A. Duprez Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review J. Hypertens. 24 2006 983 991 (Pubitemid 43772300)
-
(2006)
Journal of Hypertension
, vol.24
, Issue.6
, pp. 983-991
-
-
Duprez, D.A.1
-
5
-
-
0025688030
-
Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term
-
S.B. Harrap, W.M. Van der Merwe, S.A. Griffin, F. Macpherson, and A.F. Lever Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term Hypertension 16 1990 603 614
-
(1990)
Hypertension
, vol.16
, pp. 603-614
-
-
Harrap, S.B.1
Van Der Merwe, W.M.2
Griffin, S.A.3
MacPherson, F.4
Lever, A.F.5
-
6
-
-
52049097072
-
Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes
-
T. Imanishi, H. Tsujioka, H. Ikejima, A. Kuroi, S. Takarada, H. Kitabata, T. Tanimoto, Y. Muragaki, S. Mochizuki, M. Goto, K. Yoshida, and T. Akasaka Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes Hypertension 52 2008 563 572
-
(2008)
Hypertension
, vol.52
, pp. 563-572
-
-
Imanishi, T.1
Tsujioka, H.2
Ikejima, H.3
Kuroi, A.4
Takarada, S.5
Kitabata, H.6
Tanimoto, T.7
Muragaki, Y.8
Mochizuki, S.9
Goto, M.10
Yoshida, K.11
Akasaka, T.12
-
7
-
-
33645860811
-
Trial of Preventing Hypertension (TROPHY) study investigators: Feasibility of treating prehypertension with an angiotensin-receptor blocker
-
S. Julius, S.D. Nesbitt, B.M. Egan, M.A. Weber, E.L. Michelson, N. Kaciroti, H.R. Black, R.H. Grimm Jr., F.H. Messerli, S. Oparil, and M.A. Schork Trial of Preventing Hypertension (TROPHY) study investigators: feasibility of treating prehypertension with an angiotensin-receptor blocker N. Engl. J. Med. 354 2006 1685 1697
-
(2006)
N. Engl. J. Med.
, vol.354
, pp. 1685-1697
-
-
Julius, S.1
Nesbitt, S.D.2
Egan, B.M.3
Weber, M.A.4
Michelson, E.L.5
Kaciroti, N.6
Black, H.R.7
Grimm, Jr.R.H.8
Messerli, F.H.9
Oparil, S.10
Schork, M.A.11
-
8
-
-
54449102071
-
The PHARAO study: Prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: A prospective, randomized, controlled prevention trial of the German Hypertension League
-
PHARAO Study Group
-
S. Lüders, J. Schrader, J. Berger, T. Unger, W. Zidek, M. Böhm, M. Middeke, W. Motz, C. Lübcke, A. Gansz, L. Brokamp, R.E. Schmieder, P. Trenkwalder, H. Haller, P. Dominiak PHARAO Study Group The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League J. Hypertens. 26 2008 1487 1496
-
(2008)
J. Hypertens.
, vol.26
, pp. 1487-1496
-
-
Lüders, S.1
Schrader, J.2
Berger, J.3
Unger, T.4
Zidek, W.5
Böhm, M.6
Middeke, M.7
Motz, W.8
Lübcke, C.9
Gansz, A.10
Brokamp, L.11
Schmieder, R.E.12
Trenkwalder, P.13
Haller, H.14
Dominiak, P.15
-
9
-
-
40049111351
-
Antihypertensive therapy with aliskiren
-
DOI 10.1038/sj.ki.5002732, PII 5002732
-
F.C. Luft, and M.H. Weinberger Antihypertensive therapy with aliskiren Kidney Int. 73 2008 679 683 (Pubitemid 351323252)
-
(2008)
Kidney International
, vol.73
, Issue.6
, pp. 679-683
-
-
Luft, F.C.1
Weinberger, M.H.2
-
10
-
-
77649184417
-
Assessment and management of hypertension in children and adolescents
-
B.W. McCrindle Assessment and management of hypertension in children and adolescents Nat. Rev. Cardiol. 7 2010 155 163
-
(2010)
Nat. Rev. Cardiol.
, vol.7
, pp. 155-163
-
-
McCrindle, B.W.1
-
11
-
-
78650006983
-
Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-β1 synthesis
-
F. Mihout, N. Shweke, N. Bigé, C. Jouanneau, J.C. Dussaule, P. Ronco, C. Chatziantoniou, and J.J. Boffa Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-β1 synthesis J. Pathol. 223 2010 37 45
-
(2010)
J. Pathol.
, vol.223
, pp. 37-45
-
-
Mihout, F.1
Shweke, N.2
Bigé, N.3
Jouanneau, C.4
Dussaule, J.C.5
Ronco, P.6
Chatziantoniou, C.7
Boffa, J.J.8
-
12
-
-
77955012886
-
Novel therapeutic targets for hypertension
-
L. Paulis, and T. Unger Novel therapeutic targets for hypertension Nat. Rev. Cardiol. 7 2010 431 441
-
(2010)
Nat. Rev. Cardiol.
, vol.7
, pp. 431-441
-
-
Paulis, L.1
Unger, T.2
-
13
-
-
59949088729
-
Aliskiren: An oral direct renin inhibitor for the treatment of hypertension
-
C.A. Sanoski Aliskiren: an oral direct renin inhibitor for the treatment of hypertension Pharmacotherapy 29 2009 193 212
-
(2009)
Pharmacotherapy
, vol.29
, pp. 193-212
-
-
Sanoski, C.A.1
-
14
-
-
33645869247
-
Pharmacotherapy for prehypertension-mission accomplished?
-
H. Schunkert Pharmacotherapy for prehypertension-mission accomplished? N. Engl. J. Med. 354 2006 1742 1744
-
(2006)
N. Engl. J. Med.
, vol.354
, pp. 1742-1744
-
-
Schunkert, H.1
-
15
-
-
65249100673
-
Splice variants of neuronal nitric oxide synthase are present in the rat kidney
-
C. Smith, M. Merchant, A. Fekete, H.L. Nyugen, P. Oh, Y.L. Tain, J.B. Klein, and C. Baylis Splice variants of neuronal nitric oxide synthase are present in the rat kidney Nephrol. Dial. Transplant. 24 2009 1422 1428
-
(2009)
Nephrol. Dial. Transplant.
, vol.24
, pp. 1422-1428
-
-
Smith, C.1
Merchant, M.2
Fekete, A.3
Nyugen, H.L.4
Oh, P.5
Tain, Y.L.6
Klein, J.B.7
Baylis, C.8
-
16
-
-
34247874466
-
Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat
-
DOI 10.1152/ajprenal.00260.2006
-
Y.L. Tain, G. Freshour, A. Dikalova, K. Griendling, and C. Baylis Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat Am. J. Physiol. Renal Physiol. 292 2007 F1404 F1410 (Pubitemid 46701867)
-
(2007)
American Journal of Physiology - Renal Physiology
, vol.292
, Issue.5
-
-
Tain, Y.-L.1
Freshour, G.2
Dikalova, A.3
Griendling, K.4
Baylis, C.5
-
17
-
-
34648820108
-
Determination of dimethylarginine dimethylaminohydrolase activity in the kidney
-
DOI 10.1038/sj.ki.5002446, PII 5002446
-
Y.L. Tain, and C. Baylis Determination of dimethylarginine dimethylaminohydrolase activity in the kidney Kidney Int. 72 2007 886 889 (Pubitemid 47462078)
-
(2007)
Kidney International
, vol.72
, Issue.7
, pp. 886-889
-
-
Tain, Y.-L.1
Baylis, C.2
-
18
-
-
78349275306
-
Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats
-
Y.L. Tain, L.T. Huang, I.C. Lin, Y.T. Lau, and C.Y. Lin Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats J. Pineal. Res. 49 2010 390 398
-
(2010)
J. Pineal. Res.
, vol.49
, pp. 390-398
-
-
Tain, Y.L.1
Huang, L.T.2
Lin, I.C.3
Lau, Y.T.4
Lin, C.Y.5
-
19
-
-
77955512287
-
Melatonin blocks oxidative stress-induced increased asymmetric dimethylarginine
-
Y.L. Tain, Y.H. Kao, C.S. Hsieh, C.C. Chen, J.M. Sheen, I.C. Lin, and L.T. Huang Melatonin blocks oxidative stress-induced increased asymmetric dimethylarginine Free Radic. Biol. Med. 49 2010 1088 1098
-
(2010)
Free Radic. Biol. Med.
, vol.49
, pp. 1088-1098
-
-
Tain, Y.L.1
Kao, Y.H.2
Hsieh, C.S.3
Chen, C.C.4
Sheen, J.M.5
Lin, I.C.6
Huang, L.T.7
-
20
-
-
33744769081
-
Role of macula densa neuronal nitric oxide synthase in renal diseases
-
DOI 10.1007/s00795-006-0310-2
-
A. Tojo, M.L. Onozato, and T. Fujita Role of macula densa neuronal nitric oxide synthase in renal diseases Med. Mol. Morphol. 39 2006 2 7 (Pubitemid 44306503)
-
(2006)
Medical Molecular Morphology
, vol.39
, Issue.1
, pp. 2-7
-
-
Tojo, A.1
Onozato, M.L.2
Fujita, T.3
-
23
-
-
14044271546
-
Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats
-
DOI 10.1097/00004872-200502000-00025
-
J.M. Wood, C.R. Schnell, F. Cumin, J. Menard, and R.L. Webb Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats J. Hypertens. 23 2005 417 426 (Pubitemid 40279646)
-
(2005)
Journal of Hypertension
, vol.23
, Issue.2
, pp. 417-426
-
-
Wood, J.M.1
Schnell, C.R.2
Cumin, F.3
Menard, J.4
Webb, R.L.5
|